Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy

Maria Napolitano,1,* Ferdinando D’Amico,1,2,* Elisa Ragaini,2,* Laurent Peyrin-Biroulet,3,4 Silvio Danese1 1Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy; 2Department of Biomedical Sciences, Humanitas University, Milan,...

Полное описание

Библиографические подробности

Главные авторы:	Napolitano M, D'Amico F, Ragaini E, Peyrin-Biroulet L, Danese S
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Dove Medical Press 2022-06-01
Серии:	Drug Design, Development and Therapy
Предметы:	upadacitinib small molecule jak1 inhibitor ulcerative colitis inflammatory bowel disease
Online-ссылка:	https://www.dovepress.com/evaluating-upadacitinib-in-the-treatment-of-moderate-to-severe-active--peer-reviewed-fulltext-article-DDDT
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!